Enumeral Biomedical Corp. — Form D

Enumeral Biomedical Corp. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2014-05-07. $2.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (29)

Showing 25 of 29 people.

NameRoleLocation
Barry H BucklandDirectorNew York, NY
Emanuele H OstuniDirectorNew York, NY
Allan H RothsteinDirectorNew York, NY
John H RydzewskiDirectorNew York, NY
Arthur H TinkelenbergDirectorCambridge, MA
Michael H WeissDirectorNew York, NY
Daniel H WolfeDirectorNew York, NY
Derek H BrandExecutive OfficerNew York, NY
John H RydzewskiExecutive OfficerNew York, NY
Arthur H TinkelenbergExecutive OfficerCambridge, MA
Michael J WeissDirectorNewark, NJ
Daniel B WolfeDirectorMontclair, NJ
John J RydzewskiDirectorCambridge, MA
John J RydzewskiExecutive OfficerCambridge, MA
Allan B RothsteinDirectorCambridge, MA
Derek B BrandExecutive OfficerNew York, NY
Michael B WeissDirectorNew York, NY
Daniel WolfeDirectorNew York, NY
Emanuele OstuniDirectorNew York, NY
John RydzewskiDirectorNew York, NY
John RydzewskiExecutive OfficerNew York, NY
Arthur TinkelenbergDirectorNew York, NY
Arthur TinkelenbergExecutive OfficerNew York, NY
Barry BucklandDirectorNew York, NY
Daniel B. WolfeDirectorSalem, NH

Other filings by this issuer (4)

FiledFormOfferingSold
2014-02-10D$750K$635K
2013-05-14D$1.5M
2012-07-09D$3.0M$2.3M
2011-04-29D$3.3M$2.0M

More